Medical Associate Director, Rare Disease, Gulf
American Association of Physicists in Medicine(1 month ago)
About this role
A Medical Associate Director, Rare Disease (Therapy Area Medical Lead) for the Gulf at AstraZeneca defines the medical vision and direction for a rare disease therapeutic area across the Gulf cluster within the AstraZeneca–Alexion partnership. The role connects global and regional medical priorities with local execution, working with cross-functional stakeholders and representing the company externally. Position is based in the UAE and focuses on advancing rare disease strategies and evidence generation.
Required Skills
- Strategic Planning
- Team Leadership
- Evidence Generation
- External Engagement
- Medical Governance
- HEOR Collaboration
- Communication
- Stakeholder Management
Qualifications
- MD
- PharmD
- PhD
About American Association of Physicists in Medicine
aapm.orgN/A
View more jobs at American Association of Physicists in Medicine →Apply instantly with AI
Let ApplyBlast auto-apply to jobs like this for you. Save hours on applications and land your dream job faster.
More jobs at American Association of Physicists in Medicine
Associate Director, Cell Therapy Territory Operations Manager
American Association of Physicists in Medicine(4 days ago)
Associate Brand Manager - Lung Cancer
American Association of Physicists in Medicine(4 days ago)
Key Accounts Manager - Bangalore
American Association of Physicists in Medicine(4 days ago)
Associate Brand Manager - Hematology & Rare Disease
American Association of Physicists in Medicine(5 days ago)
Similar Jobs
Medical Science Liaison – Gulf Coast Region
Beam Therapeutics(2 months ago)
Rare Disease Pharmaceutical Sales Representative
Ashfield Healthcare, LLC(2 months ago)
VIE - Senior Manager, Medical Affairs, Rare Disease
Ipsen(15 days ago)
Rare Disease Business Manager - Toledo, OH
Takeda Pharmaceutical Company(29 days ago)
VIE - Senior Manager, Medical Affairs, Rare Disease
Ipsen(15 days ago)
Rare Disease Business Manager - Carmel, IN
Takeda Pharmaceutical Company(29 days ago)